Stromová štruktúra MeSH - rivaroxaban

[d02.886.778.727]

• chemikálie organické [d02] +
  • zlúčeniny síry [d02.886] +
    • tiofény [d02.886.778] +
      • kanagliflozín [d02.886.778.075]
      • kartikaín [d02.886.778.150]
      • duloxetín hydrochlorid [d02.886.778.260]
      • ketotifén [d02.886.778.370]
      • morantel [d02.886.778.440]
      • pizotifén [d02.886.778.580]
      • prasugrel hydrochlorid [d02.886.778.600]
      • pyrantel [d02.886.778.634] +
      • rivaroxaban [d02.886.778.727]
      • tenoyltrifluoroacetón [d02.886.778.820]
      • tienopyridíny [d02.886.778.823] +
      • kyselina tioktová [d02.886.778.827]
      • tikrynafén [d02.886.778.840]
      • tiletamín [d02.886.778.850]

[d03.383.533.640.713]

• zlúčeniny heterocyklické [d03] +
  • zlúčeniny heterocyklické s 1 jadrom [d03.383] +
    • oxazíny [d03.383.533] +
      • morfolíny [d03.383.533.640] +
        • aprepitant [d03.383.533.640.125]
        • dextromoramid [d03.383.533.640.250]
        • molsidomín [d03.383.533.640.362]
        • moricizín [d03.383.533.640.475]
        • morfolína [d03.383.533.640.562]
        • fenmetrazín [d03.383.533.640.650]
        • reboxetín [d03.383.533.640.682]
        • rivaroxaban [d03.383.533.640.713]
        • timolol [d03.383.533.640.775]
        • viloxazín [d03.383.533.640.900]
        • xamoterol [d03.383.533.640.950]

[d03.383.903.727]

• zlúčeniny heterocyklické [d03] +
  • zlúčeniny heterocyklické s 1 jadrom [d03.383] +
    • tiofény [d03.383.903] +
      • kanagliflozín [d03.383.903.075]
      • kartikaín [d03.383.903.150]
      • duloxetín hydrochlorid [d03.383.903.260]
      • ketotifén [d03.383.903.370]
      • morantel [d03.383.903.440]
      • pizotifén [d03.383.903.580]
      • prasugrel hydrochlorid [d03.383.903.600]
      • pyrantel [d03.383.903.634] +
      • rivaroxaban [d03.383.903.727]
      • tenoyltrifluoroacetón [d03.383.903.820]
      • tienopyridíny [d03.383.903.830] +
      • tikrynafén [d03.383.903.840]
      • tiletamín [d03.383.903.850]